关于吸烟对血管炎的矛盾影响的见解:综合性综述
Alireza Khabbazi1, Mehran Rahimi1, Aida Malek Mahdavi2
1Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
概括
吸烟会影响血管炎的风险和表现. 虽然它可能不会增加巨细胞动脉炎或抗中性粒细胞细胞体自身抗体相关血管炎 (AAV) 的风险,但吸烟者对Behcet风险较低.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 毒理学 毒理学 毒理学
背景情况:
- 血管炎涉及血管炎症,导致器官损伤.
- 香烟烟雾含有毒素,可以影响免疫反应和自身免疫性疾病.
- 吸烟对先天性和适应性免疫有复杂的影响.
研究的目的:
- 审查吸烟与血管炎风险相关的证据.
- 检查吸烟对临床表现,治疗反应和结果的影响.
- 评估戒烟对血管炎参数的影响.
主要方法:
- 审查现有的科学文献.
- 分析证据,将吸烟与各种类型的血管炎联系起来.
- 对血管炎患者戒烟的研究进行评估.
主要成果:
- 在吸烟者中增加巨细胞动脉炎和抗中性粒细胞体自身抗体相关血管炎 (AAV) 风险的不确定的证据.
- 强有力的证据表明,吸烟者患贝赫特病 (Behcet's disease,BD) 的风险较低.
- 吸烟改变了BD和AAV的临床表现和结果.
结论:
- 吸烟在血管炎中的作用是复杂的,并且是疾病特异性的.
- 有证据表明,吸烟对贝赫特病有保护作用.
- 吸烟显著影响某些类型的血管炎的临床过程和预后.
相关概念视频
COPD: Pathogenesis and Clinical Features
232
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
232
Disorders of the Autonomic Nervous System
561
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
561
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K
COPD: Management Using Bronchodilators and Corticosteroids
178
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
178
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K


